Analyst Ratings for Seres Therapeutics (MCRB) [Sells]
MCRB Rating Summary
MCRB Price Target Summary
- Highest: $12.00 (Jefferies)
- Lowest: $1.25 (Goldman Sachs)
- Average: $6.65
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.65 (+1066.7%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$6.65 (+1066.7%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2021 | Goldman Sachs » Updated 11/3/2023 |
Chris Shibutani | Downgrade | Sell (Neutral) |
1.25 (4.00) |
20.83 (0.57) |
-97.26% | Details |
| 8/3/2018 | BofA Securities | N/A | Downgrade | Underperform (Neutral) |
6.00 (13.00) |
7.43 (0.57) |
-92.33% | Details |
